• Home
  • NEW DAY MEDICINE
  • 4 (90) 2026
  • 85 -4 (90) 2026 - Istamov M.B., Mukhtorova Kh.K. - DEPRESSIVE DISORDERS IN TYPE 2 DIABETES MELLITUS: CURRENT STATUS, CLINICAL SIGNIFICANCE, AND APPROACHES TO DIAGNOSIS

85 -4 (90) 2026 - Istamov M.B., Mukhtorova Kh.K. - DEPRESSIVE DISORDERS IN TYPE 2 DIABETES MELLITUS: CURRENT STATUS, CLINICAL SIGNIFICANCE, AND APPROACHES TO DIAGNOSIS

DEPRESSIVE DISORDERS IN TYPE 2 DIABETES MELLITUS: CURRENT STATUS, CLINICAL SIGNIFICANCE, AND APPROACHES TO DIAGNOSIS

Istamov M.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Medical University

Mukhtorova Kh.K. - Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Medical University

Sh.Sh. Magzumova - Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Medical University

Resume

Type 2 diabetes mellitus is one of the most common chronic noncommunicable diseases and is characterized by a high risk of complications, reduced quality of life, and a significant medical and social burden. Depressive disorders occupy a special place among comorbid conditions in type 2 diabetes, occurring significantly more frequently in this category of patients than in the general population and having a significant impact on the course of the disease, glycemic control, treatment adherence, and prognosis. This article presents a review of current data on depressive disorders in type 2 diabetes, examining the bidirectional relationships between diabetes and depression, the clinical significance of affective symptoms in diabetology, the challenges of differential diagnosis, and current approaches to psychosocial screening and clinical verification of depression. It demonstrates that depression in patients with type 2 diabetes should not be considered a secondary emotional reaction to a chronic disease, but rather an independent, clinically significant factor requiring active identification and inclusion in a comprehensive, multidisciplinary patient management system.

Keywords: type 2 diabetes mellitus, depressive disorders, comorbidity, glycemic control, treatment adherence, quality of life, diagnosis.

First page

560

Last page

567

For citation:Istamov M.B., Mukhtorova Kh.K., Sh.Sh. Magzumova - DEPRESSIVE DISORDERS IN TYPE 2 DIABETES MELLITUS: CURRENT STATUS, CLINICAL SIGNIFICANCE, AND APPROACHES TO DIAGNOSIS//New Day in Medicine 4(90)2026 560-567 https://newdayworldmedicine.com/en/new_day_medicine/4-90-2026

List of References

  1. Восиков БА, Магзумова ШШ. Сравнительная динамика тревожно-депрессивной симптоматики у пациентов с различными формами гипотиреоза. Медицинский журнал молодых ученых. 2025;16(12):42–46.
  2. Ajele KW, Idemudia ES. The role of depression and diabetes distress in glycemic control: A meta-analysis. Diabetes Res Clin Pract. 2025;221. DOI: (уточнить номер DOI).
  3. American Diabetes Association Professional Practice Committee. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S86–S127. DOI: 10.2337/dc25-S005.
  4. American Diabetes Association Professional Practice Committee. Summary of revisions: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S6–S13. DOI: 10.2337/dc25-Srev.
  5. Berk M, et al. Comorbidity between major depressive disorder and physical diseases: A comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023;22(3):366–387. DOI: 10.1002/wps.21110.
  6. Beverly EA, Gonzalez JS. The interconnected complexity of diabetes and depression. Diabetes Spectr. 2025;38(1):23–31. DOI: (уточнить DOI).
  7. Centers for Disease Control and Prevention. Diabetes and mental health [Internet]. Atlanta (GA): CDC; [cited 2026 Mar 12]. Available from: https://www.cdc.gov/diabetes/living-with/mental-health.html
  8. Farooqi A, et al. A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes. Prim Care Diabetes. 2022;16(1):1–10. DOI: 10.1016/j.pcd.2021.11.009.
  9. Gonzalez JS, et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care. 2008;31(12):2398–2403. DOI: 10.2337/dc08-1341.
  10. Grenard JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: A meta-analysis. J Gen Intern Med. 2011;26(10):1175–1182. DOI: 10.1007/s11606-011-1704-y.

    file

    download